Human heterotaxy syndrome - From molecular genetics to clinical features, management, and prognosis

Circulation Journal

Volumn 76, Issue 9, 2012, Pages 2066-2075

  Shiraishi, Isao ^a   Ichikawa, Hajime ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Congenital heart disease; Genetics; Molecular biology; Surgery

Indexed keywords

ACTIVIN RECEPTOR 2; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUDESONIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH DIFFERENTIATION FACTOR 1; HEPARIN; LEFT RIGHT DETERMINATION FACTOR; PROTEIN NODAL; RETINOIC ACID; SILDENAFIL; STEROID; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR PITX2; ZINC FINGER PROTEIN;

CARDIOVASCULAR MALFORMATION; CAVOPULMONARY CONNECTION; CONGENITAL HEART MALFORMATION; FONTAN PROCEDURE; HEART; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT ISOMERISM; HEART RIGHT ISOMERISM; HEART TRANSPLANTATION; HETEROTAXY SYNDROME; HUMAN; LIVER DYSFUNCTION; MORPHOLOGY; NONHUMAN; PROGNOSIS; PROTEIN LOSING GASTROENTEROPATHY; REVIEW; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; HETEROTAXY SYNDROME; HUMANS; INFANT; PROGNOSIS;

EID: 84865480876     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0957     Document Type: Review

References (113)

1. Van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ, et al. Birth prevalence of congenital heart disease worldwide: A systematic review and meta-analysis. J Am Coll Cardiol 2011; 58: 2241-2247.
2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002; 39: 1890-1900.
3. Khairy P, Ionescu-Ittu R, Mackie AS, Abrahamowicz M, Pilote L, Marelli AJ. Changing mortality in congenital heart disease. J Am Coll Cardiol 2010; 56: 1149-1157.
4. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: Changing prevalence and age distribution. Circulation 2007; 115: 163-172.
5. Shiina Y, Toyoda T, Kawasoe Y, Tateno S, Shirai T, Wakisaka Y, et al. Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 2011; 146: 13-16.
6. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153: 807-813.
7. Lin AE, Ticho BS, Houde K, Westgate MN, Holmes LB. Heterotaxy: Associated conditions and hospital-based prevalence in newborns. Genet Med 2000; 2: 157-172.
8. Chen CM, Norris D, Bhattacharya S. Transcriptional control of leftright patterning in cardiac development. Pediatr Cardiol 2010; 31: 371-377.
9. Levin M. The embryonic origins of left-right asymmetry. Crit Rev Oral Biol Med 2004; 15: 197-206.
10. Shiratori H, Hamada H. The left-right axis in the mouse: From origin to morphology. Development 2006; 133: 2095-2104.
11. Belmont JW, Mohapatra B, Towbin JA, Ware SM. Molecular genetics of heterotaxy syndromes. Curr Opin Cardiol 2004; 19: 216-220.
12. Zhu L, Belmont JW, Ware SM. Genetics of human heterotaxias. Eur J Hum Genet 2006; 14: 17-25.
13. Jacobs JP, Anderson RH, Weinberg PM, Walters HL 3rd, Tchervenkov CI, Del Duca D, et al. The nomenclature, definition and classification of cardiac structures in the setting of heterotaxy. Cardiol Young 2007; 17(Suppl 2): 1-28.
14. Cohen MS, Anderson RH, Cohen MI, Atz AM, Fogel M, Gruber PJ, et al. Controversies, genetics, diagnostic assessment, and outcomes relating to the heterotaxy syndrome. Cardiol Young 2007; 17(Suppl 2): 29-43.
15. Bartz PJ, Driscoll DJ, Dearani JA, Puga FJ, Danielson GK, O'Leary PW, et al. Early and late results of the modified fontan operation for heterotaxy syndrome 30 years of experience in 142 patients. J Am Coll Cardiol 2006; 48: 2301-2305.
16. Serraf A, Bensari N, Houyel L, Capderou A, Roussin R, Lebret E, et al. Surgical management of congenital heart defects associated with heterotaxy syndrome. Eur J Cardiothorac Surg 2010; 38: 721-727.
17. Hoashi T, Ichikawa H, Fukushima N, Ueno T, Kogaki S, Sawa Y. Long-term clinical outcome of atrial isomerism after univentricular repair. J Card Surg 2009; 24: 19-23.
18. Ohuchi H, Kagisaki K, Miyazaki A, Kitano M, Yazaki S, Sakaguchi H, et al. Impact of the evolution of the Fontan operation on early and late mortality: A single-center experience of 405 patients over 3 decades. Ann Thorac Surg 2011; 92: 1457-1466.
19. Hamada H. Molecular mechanisms of left-right development. In: Rosenthal N, Harvey RP, editors. Heart development and regeneration. Vol 1. London: Academic Press, 297-306.
20. Kawasumi A, Nakamura T, Iwai N, Yashiro K, Saijoh Y, Belo JA, et al. Left-right asymmetry in the level of active Nodal protein produced in the node is translated into left-right asymmetry in the lateral plate of mouse embryos. Dev Biol 2011; 353: 321-330.
21. Nonaka S, Tanaka Y, Okada Y, Takeda S, Harada A, Kanai Y, et al. Randomization of left-right asymmetry due to loss of nodal cilia generating leftward flow of extraembryonic fluid in mice lacking KIF3B motor protein. Cell 1998; 95: 829-837.
22. Hirokawa N, Tanaka Y, Okada Y. Cilia, KIF3 molecular motor and nodal flow. Curr Opin Cell Biol 2012; 24: 31-39.
23. McGrath J, Somlo S, Makova S, Tian X, Brueckner M. Two populations of node monocilia initiate left-right asymmetry in the mouse. Cell 2003; 114: 61-73.
24. Shinohara K, Kawasumi A, Takamatsu A, Yoshiba S, Botilde Y, Motoyama N, et al. Two rotating cilia in the node cavity are sufficient to break left-right symmetry in the mouse embryo. Nat Commun 2012; 3: 622.
25. Tabin CJ, Vogan KJ. A two-cilia model for vertebrate left-right axis specification. Genes Dev 2003; 17: 1-6.
26. Lee JD, Anderson KV. Morphogenesis of the node and notochord: The cellular basis for the establishment and maintenance of leftright asymmetry in the mouse. Dev Dyn 2008; 237: 3464-3476.
27. Okada Y, Nonaka S, Tanaka Y, Saijoh Y, Hamada H, Hirokawa N. Abnormal nodal flow precedes situs inversus in iv and inv mice. Mol Cell 1999; 4: 459-468.
28. Supp DM, Witte DP, Potter SS, Brueckner M. Mutation of an axonemal dynein affects left-right asymmetry in inversus viscerum mice. Nature 1997; 389: 963-966.
29. Olbrich H, Häffner K, Kispert A, Völkel A, Volz A, Sasmaz G, et al. Mutations in DNAH5 cause primary ciliary dyskinesia and randomization of left-right asymmetry. Nat Genet 2002; 30: 143-144.
30. Pennekamp P, Karcher C, Fischer A, Schweickert A, Skryabin B, Horst J, et al. The ion channel polycystin-2 is required for left-right axis determination in mice. Curr Biol 2002; 12: 938-943.
31. Nonaka S, Yoshiba S, Watanabe D, Ikeuchi S, Goto T, Marshall WF, et al. De novo formation of left-right asymmetry by posterior tilt of nodal cilia. PLoS Biol 2005; 3: e268.
32. Basu B, Brueckner M. Cilia multifunctional organelles at the center of vertebrate left-right asymmetry. Curr Top Dev Biol 2008; 85: 151-174.
33. Tanaka Y, Okada Y, Hirokawa N. FGF-induced vesicular release of Sonic hedgehog and retinoic acid in leftward nodal flow is critical for left-right determination. Nature 2005; 435: 172-177.
34. Nonaka S, Shiratori H, Saijoh Y, Hamada H. Determination of leftright patterning of the mouse embryo by artificial nodal flow. Nature 2002; 418: 96-99.
35. Essner JJ, Vogan KJ, Wagner MK, Tabin CJ, Yost HJ, Brueckner M. Conserved function for embryonic nodal cilia. Nature 2002; 418: 37-38.
36. Marszalek JR, Ruiz-Lozano P, Roberts E, Chien KR, Goldstein LS. Situs inversus and embryonic ciliary morphogenesis defects in mouse mutants lacking the KIF3A subunit of kinesin-II. Proc Natl Acad Sci USA 1999; 96: 5043-5048.
37. Takeda S, Yonekawa Y, Tanaka Y, Okada Y, Nonaka S, Hirokawa N. Left-right asymmetry and kinesin superfamily protein KIF3A: New insights in determination of laterality and mesoderm induction by kif3A-/-mice analysis. J Cell Biol 1999; 145: 825-836.
38. Mitchison HM, Schmidts M, Loges NT, Freshour J, Dritsoula A, Hirst RA, et al. Mutations in axonemal dynein assembly factor DNAAF3 cause primary ciliary dyskinesia. Nat Genet 2012; 44: 381-389, S1-S2.
39. Alten L, Schuster-Gossler K, Beckers A, Groos S, Ulmer B, Hegermann J, et al. Differential regulation of node formation, nodal ciliogenesis and cilia positioning by Noto and Foxj1. Development 2012; 139: 1276-1284.
40. Krebs LT, Iwai N, Nonaka S, Welsh IC, Lan Y, Jiang R, et al. Notch signaling regulates left-right asymmetry determination by inducing Nodal expression. Genes Dev 2003; 17: 1207-1212.
41. Hadjantonakis AK, Pisano E, Papaioannou VE. Tbx6 regulates left/ right patterning in mouse embryos through effects on nodal cilia and perinodal signaling. PLoS One 2008; 3: e2511.
42. Gebbia M, Ferrero GB, Pilia G, Bassi MT, Aylsworth A, Penman-Splitt M, et al. X-linked situs abnormalities result from mutations in ZIC3. Nat Genet 1997; 17: 305-308.
43. Bedard JE, Haaning AM, Ware SM. Identification of a novel ZIC3 isoform and mutation screening in patients with heterotaxy and congenital heart disease. PLoS One 2011; 6: e23755.
44. Zhu L, Harutyunyan KG, Peng JL, Wang J, Schwartz RJ, Belmont JW. Identification of a novel role of ZIC3 in regulating cardiac development. Hum Mol Genet 2007; 16: 1649-1660.
45. Takeuchi JK, Lickert H, Bisgrove BW, Sun X, Yamamoto M, Chawengsaksophak K, et al. Baf60c is a nuclear Notch signaling component required for the establishment of left-right asymmetry. Proc Natl Acad Sci USA 2007; 104: 846-851.
46. Oki S, Kitajima K, Marques S, Belo JA, Yokoyama T, Hamada H, et al. Reversal of left-right asymmetry induced by aberrant Nodal signaling in the node of mouse embryos. Development 2009; 136: 3917-3925.
47. Larkins CE, Bushey Long A, Caspary T. Defective Nodal and Cerl2 expression in the Arl13b (hnn) mutant node underlie its heterotaxia. Dev Biol 2012; 367: 15-24.
48. Rankin CT, Bunton T, Lawler AM, Lee SJ. Regulation of left-right patterning in mice by growth/differentiation factor-1. Nat Genet 2000; 24: 262-265.
49. Tanaka C, Sakuma R, Nakamura T, Hamada H, Saijoh Y. Longrange action of Nodal requires interaction with GDF1. Genes Dev 2007; 21: 3272-3282.
50. Meno C, Saijoh Y, Fujii H, Ikeda M, Yokoyama T, Yokoyama M, et al. Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature 1996; 381: 151-155.
51. Meno C, Shimono A, Saijoh Y, Yashiro K, Mochida K, Ohishi S, et al. lefty-1 is required for left-right determination as a regulator of lefty-2 and nodal. Cell 1998; 94: 287-297.
52. Mine N, Anderson RM, Klingensmith J. BMP antagonism is required in both the node and lateral plate mesoderm for mammalian leftright axis establishment. Development 2008; 135: 2425-2434.
53. Furtado MB, Solloway MJ, Jones VJ, Costa MW, Biben C, Wolstein O, et al. BMP/SMAD1 signaling sets a threshold for the left/right pathway in lateral plate mesoderm and limits availability of SMAD4. Genes Dev 2008; 22: 3037-3049.
54. Schier AF. Nodal signaling in vertebrate development. Annu Rev Cell Dev Biol 2003; 19: 589-621.
55. Chen C, Shen MM. Two modes by which Lefty proteins inhibit nodal signaling. Curr Biol 2004; 14: 618-624.
56. Bamford RN, Roessler E, Burdine RD, Saplakoǧlu U, dela Cruz J, Splitt M, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet 2000; 26: 365-369.
57. Martin JF, Amendt BA, Brown NA. In: Rosenthal N, Harvey RP, editors. Heart development and regeneration. Vol 1. London: Academic Press, 307-322.
58. Franco D, Campione M. The role of Pitx2 during cardiac development. Linking left-right signaling and congenital heart diseases. Trends Cardiovasc Med 2003; 13: 157-163.
59. Kitamura K, Miura H, Miyagawa-Tomita S, Yanazawa M, Katoh-Fukui Y, Suzuki R, et al. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra-and periocular mesoderm and right pulmonary isomerism. Development 1999; 126: 5749-5758.
60. Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, Delpón E, et al. PITX2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet 2011; 4: 269-279.
61. Bamforth SD, Bragança J, Farthing CR, Schneider JE, Broadbent C, Michell AC, et al. Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway. Nat Genet 2004; 36: 1189-1196.
62. Lopes Floro K, Artap ST, Preis JI, Fatkin D, Chapman G, Furtado MB, et al. Loss of Cited2 causes congenital heart disease by perturbing left-right patterning of the body axis. Hum Mol Genet 2011; 20: 1097-1110.
63. Weninger WJ, Lopes Floro K, Bennett MB, Withington SL, Preis JI, Barbera JP, et al. Cited2 is required both for heart morphogenesis and establishment of the left-right axis in mouse development. Development 2005; 132: 1337-1348.
64. Mohapatra B, Casey B, Li H, Ho-Dawson T, Smith L, Fernbach SD, et al. Identification and functional characterization of NODAL rare variants in heterotaxy and isolated cardiovascular malformations. Am J Hum Genet 2007; 81: 987-994.
65. Kaasinen E, Aittomäki K, Eronen M, Vahteristo P, Karhu A, Mecklin JP, et al. Recessively inherited right atrial isomerism caused by mutations in growth/differentiation factor 1 (GDF1). Hum Mol Genet 2010; 19: 2747-2753.
66. Kosaki R, Gebbia M, Kosaki K, Lewin M, Bowers P, Towbin JA, et al. Left-right axis malformations associated with mutations in ACVR2B, the gene for human activin receptor type IIB. Am J Med Genet 1999; 82: 70-76.
67. Kosaki K, Bassi MT, Kosaki R, Lewin M, Belmont J, Schauer G, et al. Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. Am J Hum Genet 1999; 64: 712-721.
68. Kim SJ. Heterotaxy syndrome. Korean Circ J 2011; 41: 227-231.
69. Freedom RM, Jaeggi ET, Lim JS, Anderson RH. Hearts with isomerism of the right atrial appendages: One of the worst forms of disease in 2005. Cardiol Young 2005; 15: 554-567.
70. Hutter D, Redington AN. The principles of management, and outcomes for patients with functionally univentricular hearts. In: Anderson RH, Baker EJ, Penny DJ, Redington AN, Rigby ML, Wernovsky G, editors. Paediatric cardiology, 3rd edn. Philadelphia: Churchill Livingstone, 2009; 687-696.
71. Yanagawa B, Alghamdi AA, Dragulescu A, Viola N, Al-Radi OO, Mertens LL, et al. Primary sutureless repair for "simple" total anomalous pulmonary venous connection: Midterm results in a single institution. J Thorac Cardiovasc Surg 2011; 141: 1346-1354.
72. de Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: A logical alternative to atriopulmonary connection for complex Fontan operations: Experimental studies and early clinical experience. J Thorac Cardiovasc Surg 1988; 96: 682-695.
73. Salvin JW, Scheurer MA, Laussen PC, Mayer JE Jr, Del Nido PJ, Pigula FA, et al. Factors associated with prolonged recovery after the fontan operation. Circulation 2008; 118(Suppl): S171-S176.
74. Hosein RB, Clarke AJ, McGuirk SP, Griselli M, Stumper O, De Giovanni JV, et al. Factors influencing early and late outcome following the Fontan procedure in the current era: The 'Two Commandments'? Eur J Cardiothorac Surg 2007; 31: 344-352.
75. Lee TM, Aiyagari R, Hirsch JC, Ohye RG, Bove EL, Devaney EJ. Risk factor analysis for second-stage palliation of single ventricle anatomy. Ann Thorac Surg 2012; 93: 614-618.
76. Ichikawa H, Yagihara T, Kishimoto H, Isobe F, Yamamoto F, Nishigaki K, et al. Extent of aortopulmonary collateral blood flow as a risk factor for Fontan operations. Ann Thorac Surg 1995; 59: 433-437.
77. Ota N, Fujimoto Y, Murata M, Tosaka Y, Ide Y, Tachi M, et al. Improving outcomes of the surgical management of right atrial isomerism. Ann Thorac Surg 2012; 93: 832-838.
78. Ichikawa H, Sawa Y, Fukushima N, Ishizaka T, Iwai S, Kondo H, et al. Late assessment after biventricular repair for isomerism heart. Ann Thorac Surg 2005; 80: 50-55.
79. Eronen MP, Aittomäki KA, Kajantie EO, Sairanen HI. Outcome of left atrial isomerism at a single institution. Pediatr Cardiol 2012; 33: 596-600.
80. Delmo Walter EM, Ewert P, Hetzer R, Hübler M, Alexi-Meskishvili V, Lange P, et al. Biventricular repair in children with complete atrioventricular septal defect and a small left ventricle. Eur J Cardiothorac Surg 2008; 33: 40-47.
81. Uemura H, Yagihara T, Hattori R, Kawahira Y, Tsukano S, Watanabe K. Redirection of hepatic venous drainage after total cavopulmonary shunt in left isomerism. Ann Thorac Surg 1999; 68: 1731-1735.
82. Kobayashi D, Edwards HD, Singh J, Nadkarni MD, Lantz PE, Cook AL. Portopulmonary hypertension secondary to congenital extrahepatic portosystemic shunt with heterotaxy and polysplenia: A cause of sudden death in an infant. Pediatr Pulmonol 2011; 46: 1041-1044.
83. Serraf A, Bensari N, Houyel L, Capderou A, Roussin R, Lebret E, et al. Surgical management of congenital heart defects associated with heterotaxy syndrome. Eur J Cardiothorac Surg 2010; 38: 721-727.
84. Driscoll DJ. Long-term results of the Fontan operation. Pediatr Cardiol 2007; 28: 438-442.
85. Goldberg DJ, Shaddy RE, Ravishankar C, Rychik J. The failing Fontan: Etiology, diagnosis and management. Expert Rev Cardiovasc Ther 2011; 9: 785-793.
86. Khairy P, Fernandes SM, Mayer JE Jr, Triedman JK, Walsh EP, Lock JE, et al. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery: Usefulness of heparin therapy in protein-losing enteropathy associated with single ventricle palliation. Circulation 2008; 117: 85-92.
87. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129: 1348-1352.
88. Ohuchi H, Miyamoto Y, Yamamoto M, Ishihara H, Takata H, Miyazaki A, et al. High prevalence of abnormal glucose metabolism in young adult patients with complex congenital heart disease. Am Heart J 2009; 158: 30-39.
89. Drenthen W, Pieper PG, Roos-Hesselink JW, van Lottum WA, Voors AA, Mulder BJ, et al; ZAHARA Investigators. Pregnancy and delivery in women after Fontan palliation. Heart 2006; 92: 1290-1294.
90. Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28: 763-767.
91. Rychik J. Protein-losing enteropathy after Fontan operation. Congenit Heart Dis 2007; 2: 288-300.
92. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after fontan operation: Investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006; 82: 695-700.
93. Hoashi T, Ichikawa H, Ueno T, Kogaki S, Sawa Y. Steroid pulse therapy for protein-losing enteropathy after the Fontan operation. Congenit Heart Dis 2009; 4: 284-287.
94. Uzun O, Wong JK, Bhole V, Stumper O. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan. Ann Thorac Surg 2006; 82: e39-e40.
95. Vyas H, Driscoll DJ, Cabalka AK, Cetta F, Hagler DJ. Results of transcatheter Fontan fenestration to treat protein losing enteropathy. Catheter Cardiovasc Interv 2007; 69: 584-589.
96. John AS, Driscoll DJ, Warnes CA, Phillips SD, Cetta F. The use of oral budesonide in adolescents and adults with protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2011; 92: 1451-1456.
97. Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the Fontan operation. Ann Thorac Surg 2010; 89: 837-842.
98. Kanter KR, Mahle WT, Vincent RN, Berg AM, Kogon BE, Kirshbom PM. Heart transplantation in children with a Fontan procedure. Ann Thorac Surg 2011; 91: 823-829.
99. Davies RR, Sorabella RA, Yang J, Mosca RS, Chen JM, Quaegebeur JM. Outcomes after transplantation for "failed" Fontan: A singleinstitution experience. J Thorac Cardiovasc Surg 2012; 143: 1183-1192. e4.
100. Abrams DJ, Earley MJ, Sporton SC, Kistler PM, Gatzoulis MA, Mullen MJ, et al. Comparison of noncontact and electroanatomic mapping to identify scar and arrhythmia late after the Fontan procedure. Circulation 2007; 115: 1738-1746.
101. Deal BJ, Mavroudis C, Backer CL. Arrhythmia management in the Fontan patient. Pediatr Cardiol 2007; 28: 448-456.
102. Mavroudis C, Deal BJ, Backer CL, Stewart RD, Franklin WH, Tsao S, et al. J. Maxwell Chamberlain Memorial Paper for congenital heart surgery: 111 Fontan conversions with arrhythmia surgery: Surgical lessons and outcomes. Ann Thorac Surg 2007; 84: 1457-1465.
103. Bassareo PP, Tumbarello R, Piras A, Mercuro G. Evaluation of regional myocardial function by Doppler tissue imaging in univentricular heart after successful Fontan repair. Echocardiography 2010; 27: 702-708.
104. Garofalo CA, Cabreriza SE, Quinn TA, Weinberg AD, Printz BF, Hsu DT, et al. Ventricular diastolic stiffness predicts perioperative morbidity and duration of pleural effusions after the Fontan operation. Circulation 2006; 114(Suppl): I56-I61.
105. Hsu DT, Zak V, Mahony L, Sleeper LA, Atz AM, Levine JC, et al; Pediatric Heart Network Investigators. Enalapril in infants with single ventricle: Results of a multicenter randomized trial. Circulation 2010; 122: 333-340.
106. Ishibashi N, Park IS, Takahashi Y, Nishiyama M, Murakami Y, Mori K, et al. Effectiveness of carvedilol for congestive heart failure that developed long after modified Fontan operation. Pediatr Cardiol 2006; 27: 473-475.
107. Kiesewetter CH, Sheron N, Vettukattill JJ, Hacking N, Stedman B, Millward-Sadler H, et al. Hepatic changes in the failing Fontan circulation. Heart 2007; 93: 579-584.
108. Kendall TJ, Stedman B, Hacking N, Haw M, Vettukattill JJ, Salmon AP, et al. Hepatic fibrosis and cirrhosis in the Fontan circulation: A detailed morphological study. J Clin Pathol 2008; 61: 504-508.
109. Schwartz MC, Sullivan L, Cohen MS, Russo P, John AS, Guo R, et al. Hepatic pathology may develop before the Fontan operation in children with functional single ventricle: An autopsy study. J Thorac Cardiovasc Surg 2012; 143: 904-909.
110. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: Chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg 2005; 129: 1348-1352.
111. Mavroudis C, Backer CL, Deal BJ. Late reoperations for Fontan patients: State of the art invited review. Eur J Cardiothorac Surg 2008; 34: 1034-1040.
112. Backer CL, Tsao S, Deal BJ, Mavroudis C. Maze procedure in single ventricle patients. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2008; 11: 44-48.
113. Gamba A, Merlo M, Fiocchi R, Terzi A, Mammana C, Sebastiani R, et al. Heart transplantation in patients with previous Fontan operations. J Thorac Cardiovasc Surg 2004; 127: 555-562.